Sign Up Now!
To sign up for our newsletter or print publications, please enter your contact information below.
First Name *
Last Name *
Email Address (Verify) *
We will request your mailing address on the next page.
We will request your mailing address on the next page.

Meeting Highlights

Meeting Highlights
ASH Highlights
Immune Responses to COVID-19 Vaccines Low Among Patients with Hematologic Malignancies, but mRNA Vaccines Induce Strong Antibody Response in AML and MDS
Read More
Meeting Highlights
ASH Highlights
A Paradigm Shift: CAR T-Cell Therapy Beats Standard of Care as Second-Line Treatment for Large B-Cell Lymphoma
Read More
Meeting Highlights
ASH Highlights
Polatuzumab Vedotin plus R-CHP Outperforms R-CHOP as First-Line Therapy in Patients with Diffuse Large B-Cell Lymphoma
Read More
Meeting Highlights
ASH Highlights
Ivosidenib Added to First-Line Azacitidine Improves Outcomes in Older Patients with AML
Read More
Meeting Highlights
ASH Highlights
Mosunetuzumab, a Bispecific Antibody, Induces Deep Remissions in Relapsed or Refractory Follicular Lymphoma
Read More
Meeting Highlights
ASH Highlights
Isatuximab plus RVd Regimen Achieves Highest Rates of No MRD in Patients with Multiple Myeloma
Read More
Meeting Highlights
ASH Highlights
Time-Limited Venetoclax Combinations Superior to Chemoimmunotherapy in Fit Patients with CLL
Read More
Meeting Highlights
AVBCC 2021 Highlights
Using Value-Based Contracts to Manage Oncology Costs While Keeping Focus on the Patient
Read More
Meeting Highlights Online First
AVBCC 2021 Highlights
The Impact of Telehealth on Cancer Care
Read More
Meeting Highlights Online First
AVBCC 2021 Highlights
The Oncology Pipeline Overview: Recent Approvals and Near-Term Drugs
Read More
Page 1 of 16
Results 1 - 10 of 157
Copyright © Green Hill Healthcare Communications, LLC. All rights reserved.